IDEAYA Biosciences(IDYA)
Focus: IDEAYA Biosciences is a public oncology-focused biotech developing personalized synthetic medicines, headquartered in South San Francisco with 501–1000 employees. The company emphasizes precision oncology with a diversified pipeline spanning uveal melanoma, lung cancer, pancreatic cancer, and solid tumors.
Profile data last refreshed 11h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Employees
501-1000
Open Jobs
20+13 this month
Growing — net +13 jobs in 30d
18 jobs added vs 5 removed. Steady team buildout.
Should You Work at IDEAYA Biosciences?
AI assessmentHigh-risk, high-upside opportunity best suited for scientists and commercial professionals who tolerate pre-commercial risk in exchange for equity upside and precision oncology expertise.
Why Work Here
- Precision oncology focus with 11 active clinical trials across early and mid-stage development, offering deep technical exposure to targeted cancer biology.
Data completeness
5/9 — Partial
Company HealthStrong
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Revenue
$23M
Pipeline & Clinical Trials
IDE892
NSCLC AdenocarcinomaClinical Trials (1)
NCT07277413A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Phase 1Help build intelligence for IDEAYA Biosciences
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.